Ivanhoe Biotech enters into a licensing agreement with Pang Pharmaceutical for a drug under development. Ivanhoe will receive a payment of $10,100,000 if the drug receives regulatory approval. Based on prior experience in the drug-approval process, Ivanhoe determines it is 80% likely that the drug will gain approval and a 20% chance of denial.